Valo Therapeutics

Developer of immunotherapies for cancer and infectious disease

placeHelsinki, Uusimaa, Finland calendar_todayFounded 2016 groups20 employees language valotx.com

Registered entities

Innovation

9 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 302 times.

YearFilings
20161
20184
20194
20206
20215
20225
20236
20244
20253
20262

Social engagement

Social engagement: 4.9K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Freeman Road, MMJ Group Holdings, Indaco Venture Partners, CDP Venture Capital.

Investor typeCountShare
Venture capital343%
Private equity114%
Other / undisclosed343%

Recent activity

8 Jun 2026
Milestone
regulatory
24 May 2026
Event
ASCO2026
24 May 2026
Event
ASCO Annual Meeting 2026
Coming soon